Recently, Kitamura and R a j e~s k y~~ have reported that targeted disruption of the pm exon causes loss of the H chain allelic exclusion mechanism in mice heterozygous for this mutation. In animals that carried the defective pm exon at both chromosomes, no mature B cells evolve.34 Ig K chain gene rearrangement in bone marrow cells of the homozygous pm knockout mice was clearly reduced, but not absent. Similar, although less absolute, defects were observed as a result of targeted disruption of the A5 gene.35 Interestingly, pre-B cells producing pH chains without attached VH regions have been found in X-linked agammaglobulinemia patients.36 These findings suggest that the pm-$L complex serves as a variable membrane receptor on pre-B cells, which, upon binding of yet unknown ligands, transmits signals indispensible for further differentiation. Possibly, during both early and late B-cell development, cells are selected on the basis of the same principle in that they require constant signaling via mIg for their survival. This selection of B cells on the functional integrity of their mIg may guarantee that finally antibodies with optimal specificity will be secreted. In this review, we focus on structure of the human B-cell antigen receptor complex (BCR) and its role in the development of normal and neoplastic human B cells.
THE CONSTITUENTS OF THE BCR
The BCR is a multichain receptor that comprises a variant mIg glycoprotein and a recently identified heterodimer of nonvariant transmembrane (TM) proteins, referred to as Iga and Ig/3.37 Igs are tetramers constituted by pairs of disulphide-linked H and L chains. Within the Ig H and L chains, NH,-terminal variable regions and C-terminal constant regions can be distinguished. The genes that encode the antigen-binding variable regions have to be somatically assembled from individual members of variable (V), diversity (D), and joining (J) gene segment fa mi lie^.^' Two genes, recombination activation gene (RAG)-1 and RAG-2,39 have recently been identified whose products are essential for the processes of V(D)J joining at the Ig and T-cell antigen receptor (TCR) Mice that were made deficient for RAG-14' or RAG-242 via gene targeting show total inability to initiate V(D)J rearrangement and, as a consequence, have no mature B or T lymphocytes. In human B cells, assembled V, genes can recombine with nine constant (C,) (ordered 5'-Cp-C6-Cr3-Cy 1 -Ca 1 -Cy2-Cy4-Ct-Ca2-3'); in a similar fashion, V, genes unite with C, or CA gene^.^',^^ Hence, five classes of H chains and two L chain isotypes can be generated by the B-cell population. Depending on the differentiational stage of the B cell, the produced Ig H chains have hydrophobic or hydrophilic COOH-terminal segments, which determines whether Ig occurs as membrane-anchored (mIg) or secreted (sIg) molecules. All five types of antibodies (IgM, IgD, IgG, IgE, and IgA), named after the constant region of the H chain, can thus be synthesized in secreted or membrane-bound form. Mature resting B cells characteristically coexpress membrane forms of IgM and IgD, with identical variable domains.4749 The cytoplasmic tails of pm and 6m comprise only three amino acids, KVK (one letter amino acid c0de).~~7~' In the intracellular domains of mIgGS2 and mIgE,53-55 25 additional amino acids append C-terminally to the membrane-proximal KVK motif. MIgA possesses a 14 amino-acid tail, unrelated to any of the other is~types.'~'~~ The mIg-associated aP heterodimer has been biochemically defined in both mouse and human by virtue of the use of the mild detergent digitonin in immunoprecipitation studies. Under this condition, the weak noncovalent bonds between the variant and invariant complexes of immunoprecipitated BCR remain unaffected. MIgM, originating from murine or human B cells, was thus found to be associated with disulphide-linked ap dimers of approximately 34 f 39 Kd57-64 and 47/37 Kd.65-67 Surprisingly, the mIg-associated molecules had not been defined before immunologicall^,^' and still the number of Iga-and I@-reactive antibodies is limited.63,69-74 Independent of these findings, two B-lineage-specific genes mb-I 75,76 and B2977 had been isolated from murine (pre-)B-minus T-cell cDNA libraries. By transfection s t~d i e s ,~~~~~,~~-~~ amino-terminal protein seand biochemical analyses with antipeptide a n t i b~d i e s~~.~' .~~ it was established that murine mb-1 and B29 code for the 34-Kd Iga and 39-Kd IgP polypeptides, respectively. The human mb-1 81~82 and B29 genes83,84 have also been identified and code for the 47-Kd and 37-Kd mIgh4-associated molecule^.^^^^^^^^ Expression of the mb-I and B29 genes is, as may be expected on the basis of the isolation strategy, largely confined to the B-cell lineage. mb-I-and B29-derived RNA trans c r i p t~~~*~~,~' .~~,~~ and proteins69*70*72*74,85 have been detected in normal and neoplastic B cells, but not in peripheral T cells. On the other hand, low levels of mb-I mRNA have been reported for some human pre-T-and T-cell whereas in human tissue sections, smooth muscle cells and pancreatic acinar cells are stained by anti-mb-1 monoclonal antibody MOA^).^^ During B-cell differentiation, transcription of mb-1 and B29 is initiated before or simultaneously with Ig H chain gene rearrangement (Fig 2) . Expression of mb-1'' and B2977 mRNA has been reported for two murine B-precursor-cell lines whose Ig genes are in germline configuration. It is not known whether these gene transcripts are also translated, and, if so, whether mb-1 and in an mIgE+ myeloma line, not even after amplification by the polymerase chain reaction. Evidence for the physical linkage with mb-I/B29-encoded dimers on primary B cells has now been provided for three human ( 1 , (Fig 3) . The EC domain of Iga contains three cysteine residues. Most probably, two of these cysteine residues form an intrachain disulfide bond, thus defining a domain that, deduced from its amino-acid composition, has features in common with Ig-and TCR-V regioms8 Igp harbors 5 cysteine residues extracellularly, which in theory offers the opportunity to form two intrachain disulfide bonds. The covalent interaction between Iga and Igp is presumed to result from disulfide linkage of the most COOH-terminal cysteine residues found in the EC domains of these molecules.37 Different numbers of potential N-linked glycosylation sites are predicted for human Iga (6, of which 4 are known to be used6') or murine Iga (2). This finding is in agreement with biochemical data, which indicated that size differences between human and murine Iga result from an unequal degree of glycosylation. 
sylation
The minor size differences between human and murine Igp (37 Kd v 37 to 39 Kd) may indicate that murine I@ uses all of the three potential carbohydrate attachment sites. Strong evolutionary conservation has been noted for the membrane-proximal EC and TM regions of Iga (96%) and Igp (90%), which is not common for transmembrane molecules. Reconstitution studies have shown that the products of mb-I and B29 genes are both required to establish surface expression of mIg in B ce11s57~59,78,79,89 and non-B ~e l l s . '~,~~ Within the BCR, the ap heterodimer interacts with the distal c, (Cp4 and C63, respectively) and TM regions of pm and 6m H chains.59.78.90 The TM segments of different mIg isotypes are highly homologous and well conserved between species.37 They contain a number of polar serine and threonine residues that prevent incorporation of incompletely assembled, ie, nonfunctional, antigen receptors in the cell membrane." It has been postulated that the TM portions of Iga and I@, via interaction of their charged amino acids with these hydrophilic regions, form a hydrophobic sheath around mIg.37,90,9' Thus, analogous to the TCR-CD3 comp l e~,~~ only the ensemble of mIg, Iga, and Igp has the capacity to assimilate with the lipid bilayer.
Although transfection experiments in murine cells have indicated that all five mH-chain isotypes can potentially interact with the protein products ofmb-1 and B29,79 it has been questioned whether in primary B cells the various mIg isotypes, which differ significantly in their terminal Ig-like C, regions, associate with the same ap heterodimer. Particularly, isotype-specific forms of Iga have been suspected on basis of observed differences in molecular weight between mIgM-and mIgD-associated Iga molecule^^^^^^ and the finding that transfected mIgD and mIg can appear at the surface of mb-1-cells.s9,79,93 However, it is now established that Iga and Igp molecules, originating from human B-cell lines carrying different mIg classes, are derived from the same mb-I and B29 transcripts, r e s p e c t i~e l y .~~,~~ Biochemical dissimilarities between ab heterodimers thus result from different posttranslational m o d i f i~a t i o n s~~,~~,~~ dictated by the adjacent Ig H chain.79 In addition, the reported mb-l-independent membrane form of IgD59,79,93 has now been shown to represent a phosphatidylinositol (PI)-linked species.94 Selection of PI-linked variants, which most likely carry intrachain mutations, has been described before also for transfected human mIgM. 95 The significance of this finding for B-cell physiology seems limited in view of the fact that normal B cells, without exception, have an mb-I +B29+ phenotype.69,70 Indeed, we were unable to release mIgD, or any other mIg class, from the surface of human tonsillar or splenic B cells nor from a variety of B-cell lines with PI-specific phospholipase C (Lankester et al, manuscript submitted).
Recently, biochemical evidence has been obtained for a direct physical interaction of human pm, 6m, and ym H chains with their respective I@ (Van Noesel et al, manuscript submitted). This, combined with the reported absence of Igp in progenitor and terminally differentiated human B cells,70 may indicate that the appearance and For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Prototypes of the so-called receptor-kinase family, such as the platelet-derived growth factor and the epidermal growth factor receptors, possess intracellular tyrosine kinase domains whose activation coincides with ligand-induced receptor oligomerization.112,"3 As a result, tyrosine residues that are found within the same intracellular domains become auto-or cross-phosphorylated. These phospho-tyrosine residues, together with their unique peptide environment, constitute high-affinity binding sites for specific src-homology 2 (SH2) domains.'I4 Significantly, the noncatalytic SH2 domains are contained within a series of signaling proteins such as PLCy, Ras GTPase-activating protein (GAP), PI 3-kinase, and PTK of the src family.
Phosphorylation experiments, in vivo65 and in vi- press antigen-receptor-induced inositol-lipid hydrolysis, intracellular Ca2+ mobilization, and cellular activation. loo, 120,12 I Conversely, mIg-mediated protein-tyrosine phosphorylation is unimpaired in PKC-depleted B cells.1L9 This suggests that activation of PTK is a proximal event that is required for the coupling of the BCR to PLCy. It has recently been shown that, in T cells, the CD3-{ complex, after ligation by CD3 MoAb, associates with an active form of the PLCy I enzyme.Iz2 Most likely, phosphorylated tyrosine residues of CD3y, 6, t, or { are sites recognized by the PLCy 1 SH2 domain. This implies that, in view of the structural similarities as defined by the "antigen receptor tails" (Fig 4) , tyrosine residues of Iga and Ig/3 could have a similar function. Indeed, the signaling apparatus in T and B cells must be alike, because artificially expressed BCR have been shown to function in T ~e 1 l s . l~~ Several investigators have reported a physical and functional association of the BCR with src PTK-family members blk, lyn, and fyn87-L24127 and a newly defined B-cell-specific kinase, PTK72.'28-'30 Murine PTK72 is structurally related to the 70-Kd {-associated protein (ZAP-70), whose expression is limited to T and natural killer cells.'3L-133 Also, in human B cells, a 70-Kd phosphoprotein has been found in association with the BCR.s5 Recently, atk134 or BPK,'35 a novel src-like kinase has been identified that, in mutated form, has been implicated in the pathogenesis of human X-linked agammaglobulinemia (XLA). The atk gene is normally expressed during all stages of B-cell maturation, whereas it is suggested that the absence or defectiveness of its products in XLA patients provokes a block in early B-cell development. It is unclear whether atk is receptor-associated and if there is a functional connection with the BCR. At present, it is known that BCR engagement enhances the activity of the previously mentioned src-family members, PI 3 -k i n a~e ,~~* l~~ microtubule-associated protein-2 kinase (MAP-2K),L36 p2 lmS GTPase-activating protein (GAP),I3' and the product of the proto-oncogene Vav.L38.'39 An important issue to be clarified is which of the protein kinases, coisolated with the BCR, can phosphorylate the ap heterodimer and which of them represent phospho-tyrosine-"recruited" enzymes with different specificity.
THE BCR ON NEOPLASTIC HUMAN B CELLS
In lymphoma or leukemia patients, CD19+ tumor cells with rearranged Ig genes in almost all cases express mIg at the cell surface, even after years of disease. This is significant because mutations that arise in the Ig locus during the numerous replication cycles of the neoplastic cell^'^^^^^ will include stop codons and nonfunctional frameshifts. Still, selective forces seem to prevent the outgrowth of Ig-mutants. This notion is supported by the finding that relapse tumors of a follicular lymphoma, after treatment with antiidiotypic antibodies, possessed extensively modified V regions rather than having lost mlg expression.142 In addition, an oligoclonal precursor-B acute lymphoblastic leukemia has recently been described in which subclones had been generated by V-gene replacement processes.'43 Whereas in a transformed B-cell population that would be able to expand independently of mIg, two-thirds of such recombinational events would expected to be nonfunctional, in this patient, the vast majority (>90%) of tumor clones camed in-frame Ig rearrangements. These combined observations suggest that, although B-cell neoplasia are considered to be "fro- The assumption that for the expansion of malignant B cells mIg-mediated signals are also essential raises the question as to what extent the specificity of their variable receptor matters. Recently, a murine B-lymphoblastic cell line NYC has been described that depended for its growth on a cognate interaction of mIg with an endogenously produced retroviral antigen.l5I Based on the finding that FACS-sorted Ig-loss mutants of NYC could not be cultured, it was concluded that continuous antigenic stimulation accounted for the tumorigenic properties of these cells. Several investigators have reported that CD5+ B-CLL are often committed to the production of a u t o a n t i b~d i e s . '~~-'~~ This finding may be etiologically significant, as continuous engagement of the BCR by autoantigens might provide agonistic signals resulting in the persistence and accumulation of genetically altered cells in the periphery. More direct evidence for a role of antigenic stimulation in tumorigenesis in vivo has been found in lymphoma patients. Follicular lymphomas are known to have the property to somatically mutate their Ig,140.142 which, in principle, provides the possibility to study the genealogic relationship between transformed cells. Bahler and Levy'55 have recorded a follicular lymphoma patient whose cells, in the course of disease, exhibited a sequential and nonrandom pattern of VH gene mutations, strongly suggesting that clonal selection processes had influenced tumor progression. In addition, a longitudinal study of an autospecific B-cell lymphoma, performed by Friedman et al,156 showed that minor tumor clones at diagnosis became predominant in relapse samples. Markedly, the investigators were able to show that, despite this clonotypic shift, the autospecificity and idiotype of the tumor cells had been preserved. In conclusion, genetic events causing cellular transformation do not necessarily imply that cells function autonomously, in the sense that BCR signals still appear vitally important for the progression of at least some B-cell malignancies.
In view of the fact that most lymphomas and leukemias are derived from B-lineage-committed cells, which in maFor personal use only. on November 16, 2017. by guest www.bloodjournal.org From jority are mIg+, it is surprising that virtually no data exist on the configuration of their BCR. However, despite the scarcity of data on this subject, there is no reason to assume that the requirements for surface expression of mIg are different on malignant B cells. In this respect, it should be noted that much of the information regarding the structure of the human BCR is based on experiments with malignant B-cell lines.65,66,68,85,137,157 We have also performed biochemical studies on the configuration of mIg-complexes of human B-cell chronic leukemias (B-CLL) and non-Hodgkin lymphomas, and observed no major differences with normal B cells (unpublished observations). However, detailed studies on the expression and function of mb-1 and B29 in the various types of B-cell neoplasia will have to await the availability of reagents specific for the extracellular domains of Iga and I d .
CONCLUDING REMARKS
The identification of the invariant mIg-linked heterodimer allows us to study, for the first time, antigen-evoked transmembrane signaling processes in normal and neoplastic B cells at the molecular level. One of the major points to be noted is that, throughout B-cell ontogeny, the overall structure of the variable mIg receptors, but also of their putative signal transduction units, is unchanged. This finding supports the idea that B-cell differentiation progresses on the basis of repeated generation of the same stimuli. It must then be assumed that these signals are able to induce distinct transcriptional events in cells at different maturational stages. On the other hand, evidence exists that differential signals are elicited by different antigen receptors. For example, mature B cells coexpress mIgM and mIgD receptors whose constituents have identical cytoplasmic domains. Cross-linking of either of these antigen receptor classes on a monoclonal cell population is accompanied by mobilization of intracellular Caz+ 158~159 and rapid tyrosine phosphorylation of only those heterodimers that are associated with the ligated isotype.118,160 However, proliferation of the mIgM+mIgD+ cells is strongly inhibited by the antiIgM MoAb but is not affected by the IgD-specific Obviously, these disparate responses cannot, despite the newly obtained insights in the architecture of the BCR, be explained. In fact, they strongly suggest that additional, most likely membrane-associated, components contribute to the BCR. This is in agreement with observations that transfected mIg/Iga/Ig/3 complexes are, at best, partially f u n c t i~n a l .~~,~~~~~~~ The putative new members of the BCR may be constitutive associates of the antigen receptor or molecules that are assembled upon activation of the cells. In this respect, the multimeric CD19/CD21 comp l e~, '~~, '~~ whose members have been shown to associate with the BCR after mIg ~ross-linking,'~~.'~~ is a good candidate. We have recently argued why this complex might, both at the extracellular and intracellular level, offer an essential contribution to antigen-related signal amplificat i~n . '~~ MoAb. 158.1 59,161,162
NOTE ADDED IN PROOF
The structure and function of the human pre-B-cell receptor complex have now been directly addressed by Lassoued et a1 (Cell For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
